Histone Deacetylase Inhibitors Synergizes With Catalytic Inhibitors of EZH2 to Exhibit Anti-Tumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0348
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Inhibitors of Histone-Deacetylase

Journal of Applied Biomedicine
GeneticsMolecular BiologyPharmacologyBiochemistryBiological SciencesToxicologyMedicineAgriculturalNeurosciencePharmaceutics
2005English

Manipulation of B-Cell Responses With Histone Deacetylase Inhibitors

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Enhancement of Ad5-Trail Cytotoxicity Against Renal Cell Carcinoma With Histone Deacetylase Inhibitors

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2006English

Multimodal Molecular Analysis of an Atypical Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Cold Spring Harbor molecular case studies
BiochemistryMolecular MedicineGenetics
2018English

Identification of (1h)-Pyrroles as Histone Deacetylase Inhibitors With Antitumoral Activity

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) Through Multi-Kinase Inhibition

Clinical Cancer Research
Cancer ResearchOncology
2018English

Pharmacogenomics and Histone Deacetylase Inhibitors

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Displays Frequent Inactivating Germline and Somatic Mutations in SMARCA4

Nature Genetics
Genetics
2014English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy